Pathstone Family Office’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$203K	Buy	+13,094	New	+$203K	﹤0.01%	1512
2023 Q1	–	Sell	-44,422	Closed	-$462K	–	1465
2022 Q4	$462K	Buy	44,422 +20,925	+89%	+$218K	﹤0.01%	1135
2022 Q3	$305K	Buy	+23,497	New	+$305K	﹤0.01%	1216